Borja Puertas

Statistics

Publications

Citations

117

H-Index

Active since

2023

Affiliations

Instituto de Investigación Biomédica de Salamanca(Current)

Centro de Investigación del Cáncer

Centro de Investigación Biomédica en Red de Cáncer

Hospital de León

Hospital General De Segovia

Borja Puertas is an author at Instituto de Investigación Biomédica de Salamanca specializing in hematologic malignancy therapy, multiple myeloma, and multiple myeloma therapy.

ORCID

Publications per year

2023–2024

Publications

Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma

Borja Puertas, Verónica González‐Calle, Eduardo Sobejano-Fuertes et al. · Cancers · 2023 · 73 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Multiple myeloma with t(11;14): impact of novel agents on outcome

Borja Puertas, Verónica González‐Calle, Eduardo Sobejano-Fuertes et al. · Blood Cancer Journal · 2023 · 21 citations · Full text

Medicine, Hematology, Oncology +14

Randomized phase II study of weekly carfilzomib 70 mg/m<sup>2</sup> and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients

Borja Puertas, Verónica González‐Calle, Anna Sureda et al. · Haematologica · 2023 · 12 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

A research center’s experience of T-cell–redirecting therapies in triple-class refractory multiple myeloma

Borja Puertas, Adolfo Fernández-Sánchez, Elena Alejo et al. · Blood Advances · 2024 · 11 citations · Full text

Medicine, Immunology, Oncology +15

1–4 of 4